Synagis bør ikke anvendes af patienter, der kan være overfølsomme (allergiske) over for palivizumab eller andre af indholdsstofferne eller over for andre humaniserede monoklonale antistoffer.
Synagis should not be used in people who may be hypersensitive (allergic) to palivizumab or any of the other ingredients, or to other humanised monoclonal antibodies.